Diaceutics Stock

Diaceutics ROCE 2024

Diaceutics ROCE

-0.1

Ticker

DXRX.L

ISIN

GB00BJQTGV64

WKN

A2PF80

In 2024, Diaceutics's return on capital employed (ROCE) was -0.1, a -810.1% increase from the 0.01 ROCE in the previous year.

Diaceutics Aktienanalyse

What does Diaceutics do?

Diaceutics PLC is a consulting company specializing in optimizing diagnostic and treatment solutions for patients with serious and complex diseases. It was founded in 2005 by Peter Keeling in Belfast, Northern Ireland, and is now headquartered in London, UK. The company is listed on the London Stock Exchange and has offices in Europe, Asia, North America, and Australia. The business model of Diaceutics is based on the increasing number of personalized medicines on the market, targeting specific genetic markers to enable more accurate diagnosis and treatment. The company specializes in analyzing laboratory data to help doctors and pharmaceutical companies identify the specific tests needed for treating individual patients. It also offers a variety of services to optimize the use of tests in patient care. Diaceutics operates in three divisions: Diagnostic Services, Data and Analytics Services, and Strategy and Implementation Services. Diagnostic Services include optimizing diagnostic tests and identifying patient populations that would benefit from a particular treatment. Data and Analytics Services involve setting up data and analytics platforms to gain insights into the use of diagnostic tests in clinical practice. Strategy and Implementation Services support pharmaceutical companies in conducting campaigns to promote the use of diagnostic tests and increase the availability of personalized medicines. Diaceutics' products and services also include Diagnostic Insights products, providing insights into the use of diagnostic tests in various therapy areas. These insights help pharmaceutical companies optimize their personalization strategies and enhance the effectiveness of their medicines. The company also offers diagnostic programs aimed at promoting the use of diagnostic tests in clinical practice and eliminating barriers to the use of personalized medicines. Diaceutics has established partnerships with many of the world's leading diagnostic and pharmaceutical companies and also provides consulting services to support them in developing personalization strategies. Its clients include both pharmaceutical and diagnostic companies. Overall, Diaceutics has become a leading provider of personalized healthcare solutions. It occupies a unique position in the market by focusing on the intersection of diagnostics and therapy and being able to offer a wide range of products and services. Given the rapid progress in personalized medicine, Diaceutics will continue to play a significant role in optimizing diagnosis and treatment strategies and providing better care for patients. Diaceutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Diaceutics's Return on Capital Employed (ROCE)

Diaceutics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Diaceutics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Diaceutics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Diaceutics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Diaceutics stock

What is the ROCE (Return on Capital Employed) of Diaceutics this year?

The ROCE of Diaceutics is -0.1 undefined this year.

How has the ROCE (Return on Capital Employed) of Diaceutics developed compared to the previous year?

The ROCE of Diaceutics has increased by -810.1% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Diaceutics?

A high Return on Capital Employed (ROCE) indicates that Diaceutics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Diaceutics?

A low ROCE (Return on Capital Employed) can indicate that Diaceutics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Diaceutics impact the company?

An increase in the ROCE of Diaceutics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Diaceutics affect the company?

A decrease in ROCE of Diaceutics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Diaceutics?

Some factors that can affect Diaceutics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Diaceutics so important for investors?

The ROCE of Diaceutics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Diaceutics take to improve the ROCE?

To improve the ROCE, Diaceutics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Diaceutics pay?

Over the past 12 months, Diaceutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Diaceutics is expected to pay a dividend of 0 GBP.

What is the dividend yield of Diaceutics?

The current dividend yield of Diaceutics is .

When does Diaceutics pay dividends?

Diaceutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Diaceutics?

Diaceutics paid dividends every year for the past 0 years.

What is the dividend of Diaceutics?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Diaceutics located?

Diaceutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Diaceutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Diaceutics from 10/19/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 10/19/2024.

When did Diaceutics pay the last dividend?

The last dividend was paid out on 10/19/2024.

What was the dividend of Diaceutics in the year 2023?

In the year 2023, Diaceutics distributed 0 GBP as dividends.

In which currency does Diaceutics pay out the dividend?

The dividends of Diaceutics are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Diaceutics

Our stock analysis for Diaceutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Diaceutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.